Page last updated: 2024-10-25

desipramine and Arteriosclerosis

desipramine has been researched along with Arteriosclerosis in 2 studies

Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.

Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reidenberg, MM1
Affrime, M1
Pohlmeier, H1
Matussek, N1

Other Studies

2 other studies available for desipramine and Arteriosclerosis

ArticleYear
Influence of disease on binding of drugs to plasma proteins.
    Annals of the New York Academy of Sciences, 1973, Nov-26, Volume: 226

    Topics: Arrhythmias, Cardiac; Arteriosclerosis; Blood Proteins; Blood Urea Nitrogen; Carbon Radioisotopes; C

1973
[Investigations on the effect of desmethylimipramine-Pertofran on parkinsonism in man].
    Archiv fur Psychiatrie und Nervenkrankheiten, 1965, Nov-22, Volume: 207, Issue:3

    Topics: Aged; Arteriosclerosis; Desipramine; Encephalitis; Female; Humans; Male; Middle Aged; Parkinson Dise

1965